BRTX vs CE · rev $401.0K vs rev $10.28B
BioRestorative Therapies Inc (BRTX) versus Celanese Corporation (CE) — a side-by-side from cached financials, not a winner call.
BioRestorative Therapies Inc (BRTX) is a biotechnology company listed on NASDAQ.
Celanese Corporation (CE) is a chemicals company listed on US.
Latest reported BRTX revenue for 2024-12-31 was $401.0K. Net income was -$9.0M. Revenue was up 175.0% from 2023-12-31 to 2024-12-31. BRTX currently screens at market cap $10.2M.
Latest reported CE revenue for 2024-12-31 was $10.28B. Net income was -$1.51B. Revenue was down 6.0% from 2023-12-31 to 2024-12-31. CE currently screens at market cap $5.92B.
BRTX currently screens at market cap $10.2M. CE currently screens at market cap $5.92B.
Not investment advice. Open the BRTX and CE stock pages for the full models.
Not investment advice.